Medtech Insight - News And Expert Analysis For Medtech Decision Makers since 1975

Five weeks into the Middle Eastern war, petrochemical force majeure declarations are being filed, prices for a key petrochemical used in plastics are up 35% and the supply chains that produce IV bags, syringes and catheters are under compounding pressure.

The company, which ships to 56 countries and operates in six languages, said it ended last year booking deals at an annual pace of about $1.1 billion– up 103% year over year – and said it is hiring for more than 600 new roles globally in 2026.

The technetium-99m labeled, integrin αVβ3-targeting 99mTc-3PRGD2 has been approved in China as the world’s first SPECT/CT imaging agent for the diagnosis of tumors.

A new survey from Grand Avenue Software found 54% of life sciences firms were no more than “moderately” prepared for the FDA’s new Quality Management System Regulation at its February roll-out. Staffing and financial limitations, regulatory complexity, and lack of collaboration were common concerns.

The US Government Accountability Office urged the FDA to publish long‑required guidance explaining how it evaluates advisory committee member conflicts of interest, spotlighting a transparency gap that has persisted despite a congressional mandate.

Women’s health investment could exceed $600bn by 2030 as high-burden conditions like heart disease, Alzheimer’s, digital health and menopause are expected to draw more interest from investors.